Christopher Horan - May 15, 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Tech Operations Officer
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
May 15, 2025
Transactions value $
-$12,693
Form type
4
Date filed
8/18/2025, 08:15 PM
Previous filing
Feb 28, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Horan Christopher Chief Tech Operations Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Neha Krishnamohan, Attorney-in-Fact 2025-08-18 0001736819

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Tax liability -$2.86K -1.34K -1.58% $2.13 83.7K May 15, 2025 Direct F1
transaction ARTV Common Stock Tax liability -$9.84K -3.58K -4.28% $2.75 80.1K Aug 15, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.